Impact of intravenous thrombolysis on length of hospital stay in cases of acute ischemic stroke

There are limited data available on factors associated with length of stay (LOS) in cases of acute ischemic stroke according to Poisson analysis, which is more appropriate than other methods. We retrospectively reviewed medical summary charts of patients with acute ischemic stroke in 30 hospitals ac...

Full description

Saved in:
Bibliographic Details
Published in:Neuropsychiatric disease and treatment 2018-01, Vol.14, p.259-264
Main Authors: Kasemsap, Narongrit, Vorasoot, Nisa, Kongbunkiat, Kannikar, Peansukwech, Udomlack, Tiamkao, Somsak, Sawanyawisuth, Kittisak
Format: Article
Language:English
Subjects:
acute ischemic stroke
Atrial fibrillation
Cardiac arrhythmia
Comorbidity
Cost analysis
Fibrillation
Generalized linear models
Health aspects
Hemorrhage
Hospital costs
Hospital patients
Ischemia
length of stay
Medical records
Mortality
Original Research
Patients
Pneumonia
Sepsis
Stroke
Studies
thrombolysis
Urinary tract infections
Variables
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There are limited data available on factors associated with length of stay (LOS) in cases of acute ischemic stroke according to Poisson analysis, which is more appropriate than other methods. We retrospectively reviewed medical summary charts of patients with acute ischemic stroke in 30 hospitals across northeast Thailand, with the main outcome as LOS. Poisson regression was used to examine factors associated with LOS. We included 898 patients in the analysis; 460 (51.2%) were male. The median age (interquartile; IQR) was 58 (67-75) years and the median LOS was 5 (4-7) days. The median National Institute of Health Stroke Scale (NIHSS [IQR]) was 8 (4-13). Results of the analysis showed that, after controlling for age, stroke severity, atrial fibrillation, and thrombolytic use, significant variables associated with LOS were moderate stroke (incidence rate ratio [IRR] 95% confidence interval [CI] =1.15 [range 1.01-1.30], =0.040), severe stroke (IRR [95% CI] =1.27 [1.09-1.47], =0.002), thrombolytic use (IRR [95% CI] =0.68 [0.60-0.76],
ISSN:1176-6328
1178-2021
1178-2021
DOI:10.2147/ndt.s151836